Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Clinical Investigation

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI62888PMID 22772467PMCID PMC3408743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNF-α induces upregulation of EGFR expression and signaling in human colonic myofibroblasts.

  2012cited by this paper
• Relative role of methylator and tumor suppressor pathways in ulcerative colitis‐associated colon cancer

  2011cited by this paper
• Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis

  2011cited by this paper
• Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice

  2011cited by this paper
• Ulcerative colitis‐associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: A nationwide Japanese study

  2011cited by this paper
• Clinical course of colorectal cancer in patients with ulcerative colitis.

  2011cited by this paper
• The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations

  2011cited by this paper
• Involvement of interleukin-21 in the regulation of colitis-associated colon cancer

  2011cited by this paper
• Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.

  2011cited by this paper
• Characterization of Chromosomal Instability in Murine Colitis-Associated Colorectal Cancer

  2011cited by this paper
• Infant colitis--it's in the genes.

  2010cited by this paper
• MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands

  2010cited by this paper
• Lifestyle as risk factor for cancer: Evidence from human studies.

  2010cited by this paper
• Colorectal cancer molecular biology moves into clinical practice

  2010cited by this paper
• Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

  2010cited by this paper
• Understanding resistance to EGFR inhibitors—impact on future treatment strategies

  2010influential reference
• Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function

  2009cited by this paper
• Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2

  2009cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• Crypt stem cells as the cells-of-origin of intestinal cancer

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Down-regulation of Epidermal Growth Factor Receptor by Selective Expansion of a 5′-End Regulatory Dinucleotide Repeat in Colon Cancer with Microsatellite Instability

  2009cited by this paper
• Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

  2009cited by this paper
• Murine models of colorectal cancer

  2009cited by this paper
• Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

  2009cited by this paper
• Interleukin 10 (IL‐10) gene variants and susceptibility for paediatric onset Crohn’s disease

  2009cited by this paper
• Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.

  2009cited by this paper
• Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

  2009cited by this paper
• Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma

  2009cited by this paper
• Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis

  2008cited by this paper
• B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.

  2008cited by this paper
• Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

  2008cited by this paper
• Bmi1 is expressed in vivo in intestinal stem cells

  2008cited by this paper
• Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in ApcMin/+ mice

  2008cited by this paper
• Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage.

  2007cited by this paper
• Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.

  2007cited by this paper
• Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

  2007cited by this paper
• Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression

  2007cited by this paper
• Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

  2006cited by this paper
• Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.

  2006cited by this paper
• Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.

  2006cited by this paper
• KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

  2006cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation.

  2004cited by this paper
• Epidermal Growth Factor-stimulated Intestinal Epithelial Cell Migration Requires Src Family Kinase-dependent p38 MAPK Signaling*

  2004cited by this paper
• BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study.

  2004cited by this paper
• Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma.

  2004cited by this paper
• Ligand-induced, p38-dependent Apoptosis in Cells Expressing High Levels of Epidermal Growth Factor Receptor and ErbB-2*

  2004cited by this paper
• Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor

  2004cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Epidermal growth factor for ulcerative colitis.

  2003cited by this paper
• Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.

  2003cited by this paper
• Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.

  2003cited by this paper
• A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate

  2003cited by this paper
• A novel role for p120 catenin in E-cadherin function

  2002cited by this paper
• Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis

  2002cited by this paper
• The fate of low grade dysplasia in ulcerative colitis

  2002cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma

  2001cited by this paper
• The risk of colorectal cancer in ulcerative colitis: a meta-analysis

  2001cited by this paper
• Evidence for the expression of the EGF receptor on human monocytic cells.

  2001cited by this paper
• Investigation

  2000cited by this paper
• Interleukin 10‐deficient colitis: new similarities to human inflammatory bowel disease

  2000cited by this paper
• Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis.

  2000cited by this paper
• EGF Regulates Early Embryonic Mouse Gut Development in Chemically Defined Organ Culture

  2000cited by this paper
• Intestinal subepithelial myofibroblasts

  1999cited by this paper
• Myofibroblasts. II. Intestinal subepithelial myofibroblasts.

  1999cited by this paper
• Myofibroblasts. II. Intestinal subepithelial myofibroblasts.

  1999cited by this paper
• Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

  1998cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998cited by this paper
• Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility.

  1998cited by this paper
• A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation.

  1997cited by this paper
• Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line.

  1997cited by this paper
• Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

  1996cited by this paper
• The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract.

  1996influential reference
• Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.

  1996cited by this paper
• Epidermal growth factor and transforming growth factor-alpha actions on the gut.

  1995cited by this paper
• Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel diseas

  1995cited by this paper
• Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

  1995cited by this paper
• The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.

  1994cited by this paper
• Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice.

  1993cited by this paper
• Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells

  1990cited by this paper
• The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents

  1982cited by this paper
• Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

  1978cited by this paper
• Human epidermal growth factor: isolation and chemical and biological properties.

  1975cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• The multifaceted metabolite landscape of gut microbiota: systems pharmacology insights into Crohn's disease, irritable bowel disease, and ulcerative colitis.

  2026cites this paper
• Plasma Proteins Associated with the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet and Incident Dementia.

  2025cites this paper
• Intestinal epithelial PTPN23 is essential for gut barrier integrity and prevention of fatal bacterial translocation

  2025cites this paper
• Pathophysiological mechanisms underlying diarrhea across generations of EGFR-TKIs: The role of ERBB signaling and potential therapies.

  2025cites this paper
• Unique clinical, morphological, and molecular characteristics of tumors associated with PSC-IBD

  2025cites this paper
• Phenolic Extracts of Hulless Barley Grass Alleviate Progression of Colitis-Related Colorectal Cancer by Inhibiting the Overexpression of Wnt/β-Catenin Signaling Pathway.

  2025cites this paper
• 2′-Fucosyllactose transactivates EGF receptor in intestinal epithelial cells for prevention of colitis in adulthood

  2025cites this paper
• Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer.

  2024cites this paper
• Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study

  2024cites this paper
• Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing

  2023cites this paper
• Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies

  2023cites this paper
• The miR-7/EGFR axis controls the epithelial cell immunomodulation and regeneration and orchestrates the pathology in inflammatory bowel disease

  2023cites this paper
• Cortex periplocae modulates the gut microbiota to restrict colitis and colitis-associated colorectal cancer via suppression of pathogenic Th17 cells.

  2022cites this paper
• Transitional anal cells mediate colonic re-epithelialization in colitis.

  2022cites this paper
• Computer-Aided Screening and Revealing Action Mechanism of Food-Derived Tripeptides Intervention in Acute Colitis

  2022cites this paper
• Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites

  2022cites this paper
• PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression

  2022cites this paper
• Interactions between the gut microbiota-derived functional factors and intestinal epithelial cells – implication in the microbiota-host mutualism

  2022cites this paper
• Effects of Spore-Displayed p75 Protein from Lacticaseibacillus rhamnosus GG on the Transcriptional Response of HT-29 Cells

  2022cites this paper
• Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics

  2021cites this paper
• Anal skin-like epithelium mediates colonic wound healing

  2021cites this paper
• Critical role of interferons in gastrointestinal injury repair

  2021cites this paper
• Colorectal Cancer Progression Is Potently Reduced by a Glucose-Free, High-Protein Diet: Comparison to Anti-EGFR Therapy

  2021cites this paper
• Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier.

  2021cites this paper
• Mice carrying an epithelial deletion of the glucocorticoid receptor NR3C1 develop a higher tumor load in experimental colitis associated cancer.

  2021cites this paper
• Caveolar communication with xenobiotic-stalled ribosomes compromises gut barrier integrity

  2020cites this paper
• TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice

  2020cites this paper
• Caveolar communication with xenobiotic-stalled ribosomes compromises gut barrier integrity

  2020cites this paper
• Nononcogenic restoration of the intestinal barrier by E. coli-delivered human EGF.

  2019cites this paper
• Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice.

  2019cites this paper
• Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules

  2019cites this paper
• The molecular mechanism study of insulin in promoting wound healing under high‐glucose conditions

  2019cites this paper
• Prevalence of Egfr, Ki-67, Nf-Κb, Ma-1 marker in cleft affected tissue of soft palate

  2019cites this paper
• Human Colorectal Cancer from the Perspective of Mouse Models

  2019cites this paper
• The possibility of using shogaol for treatment of ulcerative colitis

  2018cites this paper
• Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes

  2018cites this paper
• Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice

  2018cites this paper
• A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity

  2018cites this paper
• Gut permeability and mucosal inflammation: bad, good or context dependent

  2017cites this paper
• The intestinal epithelial barrier: a therapeutic target?

  2017cites this paper
• ERBB4 acts as a suppressor in the development of hepatocellular carcinoma

  2017cites this paper
• EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients

  2017cites this paper
• ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation

  2017cites this paper
• EGFR-mediated Macrophage Activation Promotes Colitis-associated Tumorigenesis

  2017cites this paper
• A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo.

  2017cites this paper
• Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling

  2017cites this paper
• Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK.

  2017cites this paper
• Pathway-based Genome-wide Association Studies Reveal the Association Between Growth Factor Activity and Inflammatory Bowel Disease

  2016cites this paper
• Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancerassociated fibroblast accumulation

  2016cites this paper
• An integrative analysis of gene expression and molecular interaction data to identify dys-regulated sub-networks in inflammatory bowel disease

  2016cites this paper
• Regenerating Reputations: Are Wnt and Myc the Good Guys After All?

  2016cites this paper
• Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

  2016cites this paper
• Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease.

  2016cites this paper
• 2016 Colorectal Cancer: Global view Fibroblasts, an inconspicuous but essential player in colon cancer development and progression in colon carcinogenesis

  2016cites this paper
• Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer

  2016cites this paper
• Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.

  2015cites this paper
• Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease

  2015cites this paper
• Nuclear factor-kappaB in inflammatory bowel disease and colorectal cancer

  2015cites this paper
• Innovative and Emerging Technologies in GI Physiology and Disease Optical reconstruction of murine colorectal mucosa at cellular resolution

  2015cites this paper
• Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.

  2015cites this paper
• An EGFR Targeted PET Imaging Probe for the Detection of Colonic Adenocarcinomas in the Setting of Colitis

  2014cites this paper
• Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.

  2014cites this paper
• Activation of the Epidermal Growth Factor Receptor in Macrophages Regulates Cytokine Production and Experimental Colitis

  2014cites this paper
• Dietary flaxseed intake exacerbates acute colonic mucosal injury and inflammation induced by dextran sodium sulfate.

  2014cites this paper
• Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities.

  2014cites this paper
• Hirsutenone reduces deterioration of tight junction proteins through EGFR/Akt and ERK1/2 pathway both converging to HO-1 induction.

  2014cites this paper
• Review Article Nuclear factor-kappaB in inflammatory bowel disease and colorectal cancer

  2014cites this paper
• The wound healing, chronic fibrosis, and cancer progression triad.

  2014cites this paper
• Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer

  2013cites this paper
• The Effects of Flaxseed and Its Bioactives on Colon Health and DSS-induced Acute Colitis and Recovery in C57BL/6 Mice

  2013influential citation
• This information is current as Production and Experimental Colitis CytokineReceptor in Macrophages Regulates Activation of the Epidermal Growth Factor

  2013cites this paper
• A novel EGFR isoform confers increased invasiveness to cancer cells.

  2013cites this paper
• A Lactobacillus rhamnosus GG-derived Soluble Protein, p40, Stimulates Ligand Release from Intestinal Epithelial Cells to Transactivate Epidermal Growth Factor Receptor*

  2013cites this paper
• Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α.

  2013cites this paper
• Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK.

  2013cites this paper
• Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.

  2013cites this paper
• ErbB receptors and their growth factor ligands in pediatric intestinal inflammation

  2013cites this paper
• Epidermal growth factor receptor expression and signaling are essential in glutamine's cytoprotective mechanism in heat-stressed intestinal epithelial-6 cells.

  2013cites this paper
• Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR Therapy

  2013cites this paper
• Mascia Adverse Effects of Anti-EGFR Therapy Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of

  2013cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• The gastrointestinal tumor microenvironment.

  2013cites this paper
• Inflammation and colorectal cancer: colitis-associated neoplasia

  2012cites this paper
• Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing

  year unknowninfluential citation